Scarica l'app Stockscreener
1.01
5.38%
0.0516
Dopo l'orario di chiusura:
.98
-0.03
-2.97%
Werewolf Therapeutics Inc Borsa (HOWL) Ultime notizie
HOWL Technical Analysis & Stock Price Forecast - Intellectia AI
Investment Report: Is now the right time to enter Werewolf Therapeutics IncWeekly Trend Recap & Capital Efficient Trading Techniques - baoquankhu1.vn
Werewolf Therapeutics Faces Nasdaq Delisting Risk After Falling Below $1 Minimum Bid Price - TipRanks
HOWL Forecast, Price Target & Analyst Ratings | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - ChartMill
HOWL PE Ratio & Valuation, Is HOWL Overvalued - Intellectia AI
HOWL Should I Buy - Intellectia AI
Aug Action: Is now the right time to enter Werewolf Therapeutics Inc2026 Technical Patterns & Accurate Buy Signal Alerts - baoquankhu1.vn
Werewolf Therapeutics (HOWL) price target increased by 20.19% to 6.38 - MSN
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates - bitget.com
Werewolf Therapeutics reports Q4 EPS (20c), consensus (35c) - tipranks.com
Werewolf Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Werewolf Therapeutics, Inc. (HOWL) Reports Q4 Earnings - AlphaStreet
Werewolf Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Werewolf Therapeutics Reports 2025 Financial Results and Advances Cancer Therapy Clinical Pipeline - geneonline.com
Werewolf Therapeutics (HOWL) faces going‑concern risk while IL‑2 and IL‑12 candidates show early responses - Stock Titan
Werewolf Therapeutics 10-K: Revenue $0M, Net Loss $(60.82)M - TradingView
Earnings Scheduled For March 27, 2026 - Benzinga
HOWL: Strategic review underway with improved financials and continued progress in oncology pipeline - TradingView
Werewolf Therapeutics (NASDAQ: HOWL) cuts 2025 loss and launches strategic review - Stock Titan
Aug Drivers: Is Werewolf Therapeutics Inc a speculative investment2026 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn
Biotech 'Lowballed' Landlord On Lease Exit, Suit Says - Law360
Werewolf Therapeutics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
HOWL Stock Price, Quote & Chart | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - ChartMill
Aug Setups: Is Intelligent Bio Solutions Inc part of any major index2026 Trends & Weekly Breakout Watchlists - baoquankhu1.vn
Michael J. Urban Net Worth (2026) - GuruFocus
Werewolf Therapeutics (HOWL) eyes 2026 catalysts following FDA guidance and encouraging INDUKINE results - MSN
RSI Check: Is Werewolf Therapeutics Inc stock trending bullishTrade Exit Report & Growth Oriented Trading Recommendations - baoquankhu1.vn
Analyst Downgrade: Is now the right time to enter Werewolf Therapeutics IncLayoff News & Real-Time Volume Triggers - baoquankhu1.vn
Werewolf Therapeutics (HOWL) finance VP reports stock and option holdings on Form 3 - Stock Titan
Werewolf Therapeutics stock rises over 5% after hours on workforce reduction, including executives - MSN
Werewolf Therapeutics (HOWL) Stock Analysis Report | Financials & Insights - Benzinga Japan
Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30 - MSN
Published on: 2026-03-05 15:55:35 - baoquankhu1.vn
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives - Stocktwits
HOWL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Tuesday - Defense World
HOWL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is now the right time to enter Werewolf Therapeutics IncTrade Entry Report & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Werewolf Therapeutics Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Werewolf Therapeutics announces plan to explore strategic alternatives - MSN
Werewolf Therapeutics explores sale and strategic alternatives - Investing.com India
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives - The Manila Times
Werewolf Therapeutics Begins Strategic Alternatives Review Process - TipRanks
Werewolf Therapeutics (HOWL) starts review of strategic options with Piper Sandler - Stock Titan
Werewolf Therapeutics explores sale and strategic alternatives By Investing.com - Investing.com South Africa
Werewolf to Explore Strategic Alternatives, Engages Piper Sandler as Exclusive Advisor - TradingView
Levels Update: Does Werewolf Therapeutics Inc have strong EBITDA marginsJuly 2025 Spike Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
HOWL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Why Werewolf Therapeutics Inc. stock could rally in 2025Portfolio Gains Summary & Smart Swing Trading Techniques - mfd.ru
IPO Launch: Does Werewolf Therapeutics Inc have strong EBITDA margins2025 Analyst Calls & Risk Controlled Daily Plans - baoquankhu1.vn
Werewolf Therapeutics stock falls after announcing 64% workforce reduction By Investing.com - Investing.com Canada
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):